The Latest Breaking News from Haleon

The Microsoft Seeing AI app aims to assist people who are visually impaired with buying health products. Elin Williams, 24, author of the disability and lifestyle blog My Blurred World, gives it a go – and reveals her verdict

The depressing outcome of the split is a legal challenge in the US over Zantac that will run on for years

Advisory fee bonanza will put bread on the tables of City corporate finance professionals

Panadol and Chapstick giant joins FTSE 100

Consumer health company ends first day on London Stock Exchange with £28.5bn market valuation

Consumer healthcare business Haleon makes its debut on the London stock market today after completing its demerger from GSK.

Close on the heels of an M&A deal, GlaxoSmithKline plc (NYSE: GSK) confirmed the spin-off of the consumer healthcare business it jointly owns with U.S. pharma giant Pfizer, Inc.

Reuters Redbird Capital Buys Italian Football Club AC Milan

Pfizer Inc. (NYSE:PFE) intends to sell its 32% investment in Haleon, a consumer health joint venture with GSK plc (NYSE:GSK), after the business is spun out as an independent listed company in July, reported Reuters. Pfizer had previously indicated that it might seek to sell its stake in Haleon, a consumer health company and…